CareDx, Inc. (CDNA)
$50.64-$1.72 (-3.28%) Today
Christine Cournoyer - Director
Jeffrey Adam Novack - OfficerJeffrey Adam Novack - Officer
Michael Goldberg - DirectorCareDx Inc operates as a precision medicine company focused on the discovery, development, and commercialization of clinically differentiated, high-value healthcare solutions for transplant patients and caregivers. It offers testing services, products, and digital solutions along with the pre- and post-transplant patient journey and is a provider of genomics-based information for transplant patients. The Company's commercially available testing services consist of AlloSure Kidney, AlloMap Heart, AlloSure Heart, a dd-cfDNA solution for heart transplant patients, and AlloSure Lung, a dd-cfDNA solution for lung transplant patients. Geographically it generates the majority of its revenue from the United States. The company generates the majority of revenue from the Testing services.
| Form 4 transaction type | Transactions | Shares | Total value |
|---|---|---|---|
| Open-market sale | 15 | 326,786 | $11.92M |
| Grant or award | 8 | 70,311 | |
| Option exercise | 18 | 433,558 | |
| Tax withholding / forfeiture | 6 | 19,013 |
Dollar totals are shown for open-market purchases and sales only. Grants, option exercises, gifts and tax withholding are reported by share count because they are not trades at a market price.
94 Form 4 filings on record, the earliest from Oct 8, 2024, newest first. Filing history page 3 of 3.
| Date | Insider | Transaction | Security | Shares | Price | Value |
|---|---|---|---|---|---|---|
| Peter Maag | Open-market sale | Common Stock | 10,000 | $18.58 | $186K | |
| Hannah Valantine | Open-market sale | Common Stock | 10,570 | $19.16 | $203K | |
| Peter Maag | Open-market sale | Common Stock | 10,000 | $19.24 | $192K | |
| Richard Bryan Riggsbee | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Christine Cournoyer | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Arthur A. Torres | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Fred E. Cohen | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Hannah Valantine | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Michael Goldberg - Director | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| Peter Maag | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| George Bickerstaff | Grant or award | Common Stock | 12,103 | $0.00 | - | |
| William A. Hagstrom | Option exercise | Common Stock | 15,000 | $14.74 | $221K | |
| William A. Hagstrom | Option exercise | Common Stock | 4,391 | $7.96 | $35K | |
| William A. Hagstrom | Open-market sale | Common Stock | 19,391 | $19.90 | $386K | |
| William A. Hagstrom | Option exercise | Stock Option (right to buy) | 15,000 | $0.00 | - | |
| William A. Hagstrom | Option exercise | Stock Option (right to buy) | 4,391 | $0.00 | - | |
| Jeffrey Adam Novack - Officer | Tax withholding / forfeiture | Common Stock | 2,583 | $19.52 | $50K | |
| William A. Hagstrom | Option exercise | Common Stock | 4,745 | $4.95 | $23K | |
| William A. Hagstrom | Option exercise | Common Stock | 24,745 | $7.96 | $197K | |
| William A. Hagstrom | Option exercise | Common Stock | 510 | $5.85 | $3K | |
| William A. Hagstrom | Open-market sale | Common Stock | 30,000 | $17.45 | $523K | |
| William A. Hagstrom | Option exercise | Stock Option (right to buy) | 4,745 | $0.00 | - | |
| William A. Hagstrom | Option exercise | Stock Option (right to buy) | 24,745 | $0.00 | - | |
| William A. Hagstrom | Option exercise | Stock Option (right to buy) | 510 | $0.00 | - | |
 Abhishek Jain - Officer | Tax withholding / forfeiture | Common Stock | 1,982 | $17.63 | $35K | |
| Christine Cournoyer - Director | Option exercise | Common Stock | 29,136 | $7.96 | $232K | |
| Christine Cournoyer - Director | Open-market sale | Common Stock | 29,136 | $15.96 | $465K | |
| Christine Cournoyer - Director | Option exercise | Stock Option (right to buy) | 29,136 | $0.00 | - | |
| Christine Cournoyer - Director | Open-market sale | Common Stock | 16,700 | $14.13 | $236K | |
| Jeffrey Adam Novack - Officer | Open-market sale | Common Stock | 2,688 | $14.70 | $40K | |
| Abhishek Jain - Officer | Tax withholding / forfeiture | Common Stock | 7,686 | $15.07 | $116K | |
| Jeffrey Adam Novack - Officer | Tax withholding / forfeiture | Common Stock | 2,873 | $15.07 | $43K | |
| Peter Maag | Open-market sale | Common Stock | 13,281 | $17.23 | $229K | |
| Abhishek Jain - Officer | Tax withholding / forfeiture | Common Stock | 338 | $16.94 | $6K | |
| John Walter Hanna Jr. - Officer | Tax withholding / forfeiture | Common Stock | 61,469 | $19.16 | $1.18M | |
| Abhishek Jain - Officer | Open-market sale | Common Stock | 265 | $17.72 | $5K | |
| Jeffrey Adam Novack - Officer | Open-market sale | Common Stock | 924 | $17.72 | $16K | |
| Michael Goldberg - Director | Grant or award | Common Stock | 967 | $0.00 | - | |
| Jeffrey Adam Novack - Officer | Open-market sale | Common Stock | 1,917 | $26.00 | $50K | |
| Jeffrey Adam Novack - Officer | Open-market sale | Common Stock | 3,656 | $21.65 | $79K | |
| Jeffrey Adam Novack - Officer | Open-market sale | Common Stock | 807 | $22.00 | $18K | |
| Jeffrey Adam Novack - Officer | Open-market sale | Common Stock | 1,071 | $22.00 | $24K | |
| Jeffrey Adam Novack - Officer | Open-market sale | Common Stock | 365 | $24.00 | $9K | |
| Jeffrey Adam Novack - Officer | Open-market sale | Common Stock | 858 | $24.00 | $21K | |
| Peter Maag | Option exercise | Common Stock | 5,000 | $12.24 | $61K | |
| Peter Maag | Open-market sale | Common Stock | 5,000 | $25.00 | $125K | |
| Peter Maag | Option exercise | Stock Option (right to buy) | 5,000 | $0.00 | - | |
| Jeffrey Adam Novack - Officer | Tax withholding / forfeiture | Common Stock | 452 | $23.21 | $10K |
This is as far as the anonymous view goes. Create a free account for all 94 CDNA filings on record.
A Form 144 is notice of an INTENDED sale, not a completed one. It often precedes the Form 4 that reports the trade actually happening.
| Filed | Filer | Relationship | Shares | Market value | Notice |
|---|---|---|---|---|---|
| PETER MAAG | Director | 9,122 | $423K | View on EDGAR | |
| PETER MAAG | Director | 7,000 | $317K | View on EDGAR | |
| PETER MAAG | Director | 7,000 | $330K | View on EDGAR |
CareDx, Inc. (CDNA) had 24 insider filings in the last 90 days, with the most recent on 2026-08-06. The full record for CDNA runs to 94 Form 4 filings, the earliest from 2024-10-08. InsiderAlpha tracks every Form 4, Form 144, and 8-K filing in real time.
No insider purchases of CDNA were filed in the last 90 days.
15 insider sales of CDNA were filed in the last 90 days, totaling $11.92M.
This page tracks CDNA Form 4 insider transactions, Form 144 sale notices, and 8-K material event disclosures in one timeline. Annual 10-K and quarterly 10-Q reports live on the company's SEC EDGAR page.
Create a free InsiderAlpha account and press Watch on this page to add CDNA to your watchlist. A free account also opens the full scored daily plan with every past day and 3 months of price history. No card is required. Sign up at https://insideralpha.ai/register.
Every Form 4 below links to the original document on SEC EDGAR, so the numbers on this page can be checked against the filing they came from.
Real-time Form 4 alerts, AI-scored daily trade ideas and 10b5-1 plan flags.
